Size, Shape, and Charge of Salt-Free Catanionic Microemulsion Droplets: A Small-Angle Neutron Scattering and Modeling Study

Development and Evaluation of Self-Emulsifying Drug-Delivery System-Based Tablets for Simvastatin, a BCS Class II Drug

Background

Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant.

Methods

The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches.

Results

The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%-101%). The crushing strength of all formulations was in the range of 58-96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min.

Conclusion

Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin.

Advances in microfluidic synthesis and coupling with synchrotron SAXS for continuous production and real-time structural characterization of nano-self-assemblies

Microfluidic platforms have become highly attractive tools for synthesis of nanoparticles, including lipid nano-self-assemblies, owing to unique features and at least three important aspects inherent to miniaturized micro-devices. Firstly, the fluids flow under controlled conditions in the microchannels, providing well-defined flow profiles and shorter diffusion lengths that play important roles in enhancing the continuous production of lipid and polymer nanoparticles with relatively narrow size distributions. Secondly, various geometries adapted to microfluidic device designs can be utilized for enhancing the colloidal stability of nanoparticles and improving their drug loading. Thirdly, microfluidic devices are usually compatible with in situ characterization methods for real-time monitoring of processes occurring inside the microchannels. This is unlike conventional nanoparticle synthesis methods, where a final solution or withdrawn aliquots are separately analysed. These features inherent to microfluidic devices provide a tool-set allowing not only precise nanoparticle size control, but also real-time analyses for process optimization. In this review, we focus on recent advances and developments in the use of microfluidic devices for synthesis of lipid nanoparticles. We present different designs based on hydrodynamic flow focusing, droplet-based methods and controlled microvortices, and discuss integration of microfluidic platforms with synchrotron small-angle X ray scattering (SAXS) for in situ structural characterization of lipid nano-self-assemblies under continuous flow conditions, along with major challenges and future directions in this research area.

Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment

Cancer is an extremely complex disease, typically caused by mutations in cancer-critical genes. By delivering therapeutic nucleic acids (NAs) to patients, gene therapy offers the possibility to supplement, repair or silence such faulty genes or to stimulate their immune system to fight the disease. While the challenges of gene therapy for cancer are significant, the latter approach (a type of immunotherapy) starts showing promising results in early-stage clinical trials. One important advantage of NA-based cancer therapies over synthetic drugs and protein treatments is the prospect of a more universal approach to designing therapies. Designing NAs with different sequences, for different targets, can be achieved by using the same technologies. This versatility and scalability of NA drug design and production on demand open the way for more efficient, affordable and personalized cancer treatments in the future. However, the delivery of exogenous therapeutic NAs into the patients’ targeted cells is also challenging. Membrane-type lipids exhibiting permanent or transient cationic character have been shown to associate with NAs (anionic), forming nanosized lipid-NA complexes. These complexes form a wide variety of nanostructures, depending on the global formulation composition and properties of the lipids and NAs. Importantly, these different lipid-NA nanostructures interact with cells via different mechanisms and their therapeutic potential can be optimized to promising levels in vitro. The complexes are also highly customizable in terms of surface charge and functionalization to allow a wide range of targeting and smart-release properties. Most importantly, these synthetic particles offer possibilities for scaling-up and affordability for the population at large. Hence, the versatility and scalability of these particles seem ideal to accommodate the versatility that NA therapies offer. While in vivo efficiency of lipid-NA complexes is still poor in most cases, the advances achieved in the last three decades are significant and very recently a lipid-based gene therapy medicine was approved for the first time (for treatment of hereditary transthyretin amyloidosis). Although the path to achieve efficient NA-delivery in cancer therapy is still long and tenuous, these advances set a new hope for more treatments in the future. In this review, we attempt to cover the most important biophysical and physicochemical aspects of non-viral lipid-based gene therapy formulations, with a perspective on future cancer treatments in mind.

SAXS on a chip: from dynamics of phase transitions to alignment phenomena at interfaces studied with microfluidic devices

The field of microfluidics offers attractive possibilities to perform novel experiments that are difficult (or even impossible) to perform using conventional bulk and surface-based methods. Such attractiveness comes from several important aspects inherent to these miniaturized devices. First, the flow of fluids under submillimeter confinement typically leads to a drop of inertial forces, meaning that turbulence is practically suppressed. This leads to predictable and controllable flow profiles, along with well-defined chemical gradients and stress fields that can be used for controlled mixing and actuation on the micro and nanoscale. Secondly, intricate microfluidic device designs can be fabricated using cleanroom standard procedures. Such intricate geometries can take diverse forms, designed by researchers to perform complex tasks, that require exquisite control of flow of several components and gradients, or to mimic real world examples, facilitating the establishment of more realistic models. Thirdly, microfluidic devices are usually compatible with in situ or integrated characterization methods that allow constant real-time monitoring of the processes occurring inside the microchannels. This is very different from typical bulk-based methods, where usually one can only observe the final result, or otherwise, take quick snapshots of the evolving process or take aliquots to be analyzed separately. Altogether, these characteristics inherent to microfluidic devices provide researchers with a set of tools that allow not only exquisite control and manipulation of materials at the micro and nanoscale, but also observation of these effects. In this review, we will focus on the use and prospects of combining microfluidic devices with in situ small-angle X-ray scattering (and related techniques such as small-angle neutron scattering and X-ray photon correlation spectroscopy), and their enormous potential for physical-chemical research, mainly in self-assembly and phase-transitions, and surface characterization.

Potentials and challenges in self-nanoemulsifying drug delivery systems

INTRODUCTION

A significant number of new chemical entities (almost 40%), that are outcome of contemporary drug discovery programs, have a potential therapeutic promise for patient, as they are highly potent but poorly water soluble resulting in reduced oral bioavailability. Self-nanoemulsifying drug delivery systems (SNEDDS) have emerged as a vital strategy to formulate these poorly soluble compounds for bioavailability enhancement.

AREAS COVERED

The review gives an insight about potential of SNEDDS with regards to oral drug delivery. The effect of various key constituents on formulation of SNEDDS and their applications in oral drug delivery is also discussed. Various aspects of formulation, characterization and biopharmaceutical aspects of SNEDDS are also been explored. The choice and selection of excipients for development of SNEDDS is also discussed.

EXPERT OPINION

The ability of SNEDDS to present the drug in single unit dosage form either as soft or hard gelatin capsule with enhanced solubility maintaining the uniformity of dose is unique. With the ease of large-scale production, high drug-loading capacity, improvement in release behavior of poorly water-soluble drugs and improvement of oral bioavailability, SNEDDS have emerged as preferable system for the formulation of drug compounds with bioavailability problems due to poor aqueous solubility.

Phase behavior and rheological properties of salt-free catanionic TTAOH/DA/H2O system in the presence of hydrophilic and hydrophobic salts

In the cationic and anionic (catanionic) surfactant mixed system, tetradecyltrimethylammonium hydroxide (TTAOH)/decanoic acid (DA)/H(2)O, abundant phase behaviors were obtained in the presence of hydrophilic and hydrophobic salts. The microstructures of typical L(α) phases with the different compositions were characterized by the transmission electron microscope (TEM) images. Aqueous double-phase transition induced by addition of hydrophilic salts was observed when the cationic surfactant was in excess. Salt-induced reversible vesicle phases could be obtained when the anionic surfactant was excess, whereas the vesicle phase at lower salinity behaves highly viscoelastic but is much less viscoelastic with high salinity which was demonstrated by measuring their rheological properties. The L(α) phase with the positive membrane charges can be finally transferred into an L(1) phase with added salts. The ion specificity of hydrophilic and hydrophobic salts is discussed, and the order of cations is summarized, which is significant for the further study of the Hofmeister effects on catanionic surfactant mixed systems.

Headgroup effects on the unusual lamellar-lamellar coexistence and vesicle-to-micelle transition of salt-free catanionic amphiphiles

Salt-free ion-paired catanionic amphiphiles of the C(m)(+)C(n)(-) type, with a high solubility mismatch (n >> m or m >> n) display a remarkable phase behavior in water. A temperature-driven vesicle-to-micelle transition in the dilute side together with a coexistence of two lamellar phases on the concentrated side is one of the peculiar effects that have been reported for the hexadecyltrimethylammonium octylsulfonate surfactant, C(16)C(8) or TA(16)So(8) (extensive to C(14)C(8) and C(12)C(8)). In this work, with TA(16)So(8) as a reference, the cationic trimethylammonium (TA(+)) and pyridinium (P(+)) headgroups are combined with the anionic sulfate (S(-)) and sulfonate (So(-)) headgroups to yield other C(16)C(8) compounds: hexadecyltrimethylammonium octylsulfate (TA(16)S(8)), 1-hexadecylpyridinium octylsulfonate (P(16)So(8)), and 1-hexadecylpyridinium octylsulfate (P(16)S(8)). We show that, if the asymmetry of the chain lengths is kept constant at C(16)C(8) and the headgroup chemistry is changed, most of the unusual self-assembly properties are still observed, indicating that they are not system-specific but extensive to other combinations of headgroups and mainly dictated by the ion-pair solubility mismatch. Thus, all the compounds in water quite remarkably show a lamellar-lamellar phase coexistence and spontaneously form vesicles upon solubilization. Moreover, P(16)So(8) undergoes a temperature-driven vesicle-to-micelle transition that involves an intermediate planar lamellar state, similar to TA(16)So(8). Some interesting effects on the global phase behavior, however, do arise when the headgroups are changed. Geometric packing effects are shown to be important, but the differences in phase behavior seem to be mainly dictated by (i) the charge density of the headgroups, which tunes the solubility mismatch of the ion-pair, and (ii) specific interactions between headgroups, which affect the short-range repulsive force that controls the swelling of the concentrated lamellar phase.